Home  >  Products  >  DRD3 (dopamine receptor D3 ) Blocking Peptide (the C terminal of DRD3)(100ug)
DRD3 (dopamine receptor D3 ) Blocking Peptide (the C terminal of DRD3)(100ug)

DRD3 (dopamine receptor D3 ) Blocking Peptide (the C terminal of DRD3)(100ug)


Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-DRD3 Antibody (ARP63162_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP63162
Size: 100ug
Weight: 41kDa
Gene: The peptide is characterized by mass spectroscopy
Format: Lyophilized powder
Target: This gene encodes the D3 subtype of the five (D1-D5) dopamine receptors. The activity of the D3 subtype receptor is mediated by G proteins which inhibit adenylyl cyclase. This receptor is localized to the limbic areas of the brain, which are associated with cognitive, emotional, and endocrine functions. Genetic variation in this gene may be associated with susceptibility to hereditary essential tremor 1. Alternative splicing of this gene results in transcript variants encoding different isoforms, although some variants may be subject to nonsense-mediated decay (NMD).
Alternative names: D3DR; ETM1; FET1; MGC149204; MGC149205